Login

Healthcare

00:00:00
ProMIS Neurosciences reckons it has the only assets to tackle - Eugene William , Promis Neurosciences Inc
00:00:00
Probiodrug pursues modified abeta approach to tackle Alzheimer's- Dr. Konrad Glund, CEO, Probiodrug
00:00:00
Steve Harr, CEO of Sana Biotechnology
00:00:00
Chris von Jako, chief executive of Polarean, about the company’s five pillar strategy to drive uptake of its life saving lung imaging technology. Chris von Jako, chief executive of Polarean, about the company’s five pillar strategy to drive uptake of it
00:00:00
Polarean Imaging receives "clear indication of belief in the company" from major shareholder - Dr. Christopher von Jako Chief Executive Officer, Polarean Imaging
00:00:00
PledPharma CEO, Nicklas Westerholm
00:00:00
EnterNext welcomes Plant Advanced Technologies on Alternext in Paris - Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies
00:00:00
Pixium Vision - executive interview / Lloyd Diamond CEO, Pixium Vision
00:00:00
Lloyd Diamond - Pixium Vision CEO, Pixium Vision
00:00:00
Pixium Vision | Lloyd Diamond - President & CEO
00:00:00
Lloyd Diamond Presents Pixium Vision - Lloyd Diamond CEO, Pixium Vision
00:00:00
Phylogica (ASX:PYC) talks strategy and platform direction - Stephanie Unwin, CEO, Phylogica Ltd
00:00:00
Dr. Mariola Söhngen Chief Executive Officer and Executive Director, Proteome Sciences
00:00:00
Proteomics International focused on first commercial sales for PromarkerD in USA - Dr Richard Lipscombe, MD, Proteomics International Laboratories Ltd
00:00:00
Realm Therapeutics plc - Equity Development Investor Forum - Alex Martin, CEO, Realm Therapeutics
00:00:00
Gary Phillips, CEO of Australian biopharma company, Pharmaxis Ltd, discusses ensuring continuity of supply of its products - Gary Phillips, CEO, Pharmaxis Ltd

© 2026 Nehu